Ipsen S.A. (EPA:IPN)
159.60
-2.90 (-1.78%)
Apr 21, 2026, 5:22 PM CET
Ipsen Employees
Ipsen had 5,535 employees as of December 31, 2025. The number of employees increased by 177 or 3.30% compared to the previous year.
Employees
5,535
Change (1Y)
177
Growth (1Y)
3.30%
Revenue / Employee
€709,883
Profits / Employee
€80,126
Market Cap
13.34B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5,535 | 177 | 3.30% | 5,535 | 0 |
| Dec 31, 2024 | 5,358 | 33 | 0.62% | 5,358 | 0 |
| Dec 31, 2023 | 5,325 | 253 | 4.99% | 5,325 | 0 |
| Dec 31, 2022 | 5,072 | -672 | -11.70% | 5,072 | 0 |
| Dec 31, 2021 | 5,744 | 41 | 0.72% | 5,744 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 155,975 |
| emeis Société anonyme | 83,500 |
| Sanofi | 74,846 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,694 |
| Ramsay Générale de Santé | 40,000 |
| bioMérieux | 15,226 |
| Sartorius Stedim Biotech | 10,265 |
Ipsen News
- 2 months ago - Ipsen S.A. publishes its 2025 Consolidated Financial Statements - GlobeNewsWire
- 9 months ago - Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) - GlobeNewsWire
- 11 months ago - Ipsen S.A. - Initiation of the share buy-back program - GlobeNewsWire
- 11 months ago - Ipsen S.A. - Annual General Meeting held on 21 May 2025 - GlobeNewsWire
- 1 year ago - Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting - GlobeNewsWire
- 1 year ago - Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance - GlobeNewsWire
- 1 year ago - Employee of French drugmaker Ipsen to plead guilty to US insider trading - Reuters
- 1 year ago - Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024) - GlobeNewsWire